Results of first-ever study to be presented at annual meeting of the American Heart Association in Orlando, Nov. 16
Patients with coronary heart disease who practiced the stress-reducing Transcendental Meditation® technique had nearly 50 percent lower rates of heart attack, stroke, and death compared to nonmeditating controls, according to the results of a first-ever study presented during the annual meeting of the American Heart Association in Orlando, Fla., on Nov.16, 2009
The Medical College of Wisconsin has been awarded a five-year, $8 million, multi-investigator Program Project Grant (PPG) from the National Institutes of Health to understand how human pluripotent stem cells, defined as cells which if left to their own designs can develop into any of the more than 200 cell types in the human body, can be channeled to exclusively become heart muscle cells.
Tom P. Aufderheide, MD, an internationally recognized researcher in the field of emergency cardiac care at The Medical College of Wisconsin, was one of 65 people in the United States and five foreign associates elected to membership in the Institute of Medicine (IOM) of the National Academy of Sciences. Election to the IOM is considered one of the highest honors in the fields of health and medicine and recognizes individuals who have demonstrated outstanding professional achievement and commitment to service.
Sept 21 - Radiologists at the Medical College of Wisconsin have discovered that prospective electrocardiogram (ECG) gating allows them to significantly reduce the patient radiation dose delivered during computed tomography (CT) angiography, a common noninvasive technique used to evaluate vascular disease. Electrocardiogram gating is a method of capturing images of the heart and great vessels when there is least movement.
Sept 10 - Researchers at The Medical College of Wisconsin in Milwaukee have identified the genetic region in rats responsible for cardiovascular collapse during anesthesia. While it is well known that people have different cardiovascular sensitivity to anesthesia causing some to collapse even when low doses are administered, the mechanism responsible for this susceptibility is not clear.
Aug 3 - Interventional cardiologist Panayotis Fasseas, MD, has been appointed Assistant Professor of Medicine (Cardiovascular Medicine) at The Medical College of Wisconsin and to the medical staff at Froedtert Hospital, a major teaching affiliate of the Medical College.
Paul O’Connor, PhD, has been appointed assistant professor of physiology at The Medical College of Wisconsin. His research interest is in the control of blood pressure, and how sodium transport and the production of oxygen free radicals may be altered in the kidneys of salt-sensitive individuals.
July 7 - Medical College of Wisconsin researchers at Children’s Hospital of Wisconsin and Froedtert Hospital, in collaboration with Massachusetts General Hospital are conducting a research study to determine the genetic links to mitral valve prolapse (MVP). MVP is a common heart disorder with a strong hereditary component.
July 6 - Matthias L. Riess, MD, PhD, assistant professor of anesthesiology and physiology, was named the first recipient of the Roizen Anesthesia Research Foundation New Roizen Investigator grant. The two-year, $100,000 grant from the Society of Cardiovascular Anesthesiologists Foundation supports an early career investigator conducting research in the field of cardiovascular anesthesiology.
July 6 - Medical College of Wisconsin physicians at Froedtert Hospital are participating in a national clinical trial to evaluate the IBV® Valve System, an investigative minimally invasive device for the treatment of severe emphysema. Safety and effectiveness data from this research study of the IBV® Valve will be submitted to the U.S. Food and Drug Administration for approval to market the device in the United States.
June 23 - The Medical College of Wisconsin received a four year, $1.5 million grant from the National Institutes of Health’s National Heart, Lung and Blood Institute to study the role of naturally produced hydrogen peroxide in controlling human blood flow. This process has considerable relevance for patients with coronary artery disease.
June 10 - Allen W. Cowley Jr., PhD, chairman and professor of physiology, has been appointed director of the cardiovascular center by Jonathan I. Ravdin, MD, dean and executive vice president, effective July 1. He succeeds David R. Harder, PhD, Kohler Co. Professor in Cardiovascular Research, who has served as acting director of the center since June 2008, when he was promoted to associate dean of research.
June 8 - Medical College of Wisconsin researchers are enrolling adults with congenital heart disease in a national research study. They are inviting patients who are referred to the Adult Congenital Heart Disease Program.
April 27 - The Medical College of Wisconsin received a four-year, $2 Million grant from the National Institutes of Health’s National Heart, Lung, and Blood Institute to investigate the molecular mechanisms that control heart development. Understanding this mechanism will provide greater insight into the molecular basis of congenital heart disease and its prevention.
April 22 - The Medical College of Wisconsin received a four-year, $1,413,000 grant from the National Institutes of Health’s National Heart, Lung, and Blood Institute to develop new drug treatments for cardiac disease prevention.